| # | Drug | Count |
|---|---|---|
| 0 | CARBAMAZEPINE | 15 |
| 1 | CITALOPRAM | 9 |
| 2 | CITALOPRAM HYDROBROMIDE | 8 |
| 3 | LAMIVUDINE AND ZIDOVUDINE | 8 |
| 4 | PREGABALIN | 8 |
| 5 | VENLAFAXINE HYDROCHLORIDE | 8 |
| 6 | DIAZEPAM | 7 |
| 7 | DIAZEPAM ORAL | 7 |
| 8 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 7 |
| 9 | QUETIAPINE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L DOPA | 1 | 0.0037 |
| 1 | ONASEMNOGENE ABEPARVOVEC-XIOI | 4 | 0.0017 |
| 2 | LAROTRECTINIB | 1 | 0.0011 |
| 3 | LAMIVUDINE AND ZIDOVUDINE | 8 | 0.0010 |
| 4 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 5 | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | 1 | 0.0006 |
| 6 | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | 1 | 0.0006 |
| 7 | LARONIDASE | 2 | 0.0005 |
| 8 | RISDIPLAM | 2 | 0.0005 |
| 9 | NEVIRAPINE | 4 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 2 | 0.0005 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 4 | 0.0003 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0002 |
| 4 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0002 |
| 6 | Protease Inhibitor [EPC] | 7 | 0.0002 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 7 | 0.0001 |
| 8 | Vitamin K [EPC] | 1 | 0.0001 |
| 9 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |